Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

BACKGROUND: We compared the efficacy of two different taxanes, docetaxel and paclitaxel, given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer. METHODS: We enrolled 4950 women with axillary lymph node–positive or high-risk, lymph node–negative breast cancer. After randomiz...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sparano, Joseph A., Wang, Molin, Martino, Silvana, Jones, Vicky, Perez, Edith A., Saphner, Tom, Wolff, Antonio C., Sledge, George W., Wood, William C., Davidson, Nancy E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743943/
https://ncbi.nlm.nih.gov/pubmed/18420499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0707056
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky